Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2010 | 04-2009 | 04-2008 | 04-2007 | 04-2006 | |
| Sales | 4,893 | 3,710 | 1,400 | 0 | 0 |
| Cost of Goods | 1,915 | 1,908 | 490 | N/A | N/A |
| Gross Profit | 2,978 | 1,802 | 910 | N/A | N/A |
| Operating Expenses | 6,821 | 5,040 | 1,840 | 170 | 144 |
| Operating Income | -2,928 | -2,330 | -440 | -170 | -144 |
| Other Income | 5 | 88 | 29 | 0 | 0 |
| Pre-tax Income | -2,923 | -2,242 | -411 | -170 | -144 |
| Net Income Continuous | -2,923 | -2,242 | -411 | -170 | -144 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -160 |
| Net Income | $-2,923 | $-2,242 | $-411 | $-170 | $-304 |
| EPS Basic Total Ops | -1.08 | -0.84 | -0.12 | -0.12 | -0.24 |
| EPS Basic Continuous Ops | -1.04 | -0.81 | -0.16 | -0.10 | -0.10 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -0.11 |
| EPS Diluted Total Ops | -1.08 | -0.84 | -0.12 | -0.12 | -0.24 |
| EPS Diluted Continuous Ops | -1.04 | -0.81 | -0.16 | -0.10 | -0.10 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.11 |
| EBITDA(a) | $-2,896 | $-2,326 | $-440 | $-159 | $-144 |